WallStreetZenWallStreetZen

NASDAQ: BPTH
Bio Path Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BPTH

Based on 1 analyst offering 12 month price targets for Bio Path Holdings Inc.
Min Forecast
$20.00+2,250.18%
Avg Forecast
$20.00+2,250.18%
Max Forecast
$20.00+2,250.18%

Should I buy or sell BPTH stock?

Based on 1 analyst offering ratings for Bio Path Holdings Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BPTH stock forecasts and price targets.

BPTH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-07-08

1 of 1

Forecast return on equity

Is BPTH forecast to generate an efficient return?
Company
-747.27%
Industry
-748.45%
Market
49.39%
BPTH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BPTH forecast to generate an efficient return on assets?
Company
-188.5%
Industry
26.75%
BPTH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BPTH earnings per share forecast

What is BPTH's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$6.20
Avg 2 year Forecast
-$4.04
Avg 3 year Forecast
-$3.91

BPTH revenue forecast

What is BPTH's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$55.8M
Avg 2 year Forecast
$84.9M
Avg 3 year Forecast
$115.2M

BPTH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BPTH$0.85$20.00+2,250.18%Strong Buy
GLMD$4.11N/AN/A
THAR$1.92N/AN/A
TRVN$2.50$125.00+4,900.00%Buy
OGEN$0.40N/AN/A
View Top Biotech Stocks

Bio Path Holdings Stock Forecast FAQ

Is Bio Path Holdings Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BPTH) stock is to Strong Buy BPTH stock.

Out of 1 analyst, 1 (100%) are recommending BPTH as a Strong Buy, 0 (0%) are recommending BPTH as a Buy, 0 (0%) are recommending BPTH as a Hold, 0 (0%) are recommending BPTH as a Sell, and 0 (0%) are recommending BPTH as a Strong Sell.

If you're new to stock investing, here's how to buy Bio Path Holdings stock.

What is BPTH's earnings growth forecast for 2024-2026?

(NASDAQ: BPTH) Bio Path Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.77%.

Bio Path Holdings's earnings in 2024 is -$11,597,000.On average, 1 Wall Street analyst forecast BPTH's earnings for 2024 to be -$15,823,578, with the lowest BPTH earnings forecast at -$15,823,578, and the highest BPTH earnings forecast at -$15,823,578. On average, 1 Wall Street analyst forecast BPTH's earnings for 2025 to be -$10,310,848, with the lowest BPTH earnings forecast at -$10,310,848, and the highest BPTH earnings forecast at -$10,310,848.

In 2026, BPTH is forecast to generate -$9,979,063 in earnings, with the lowest earnings forecast at -$9,979,063 and the highest earnings forecast at -$9,979,063.

What is BPTH's revenue growth forecast for 2028-2030?

(NASDAQ: BPTH) Bio Path Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.66%.

Bio Path Holdings's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast BPTH's revenue for 2028 to be $142,412,202, with the lowest BPTH revenue forecast at $142,412,202, and the highest BPTH revenue forecast at $142,412,202. On average, 1 Wall Street analysts forecast BPTH's revenue for 2029 to be $216,680,931, with the lowest BPTH revenue forecast at $216,680,931, and the highest BPTH revenue forecast at $216,680,931.

In 2030, BPTH is forecast to generate $294,088,854 in revenue, with the lowest revenue forecast at $294,088,854 and the highest revenue forecast at $294,088,854.

What is BPTH's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BPTH) forecast ROA is -188.5%, which is lower than the forecast US Biotechnology industry average of 26.75%.

What is BPTH's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BPTH price target, the average BPTH price target is $20.00, with the highest BPTH stock price forecast at $20.00 and the lowest BPTH stock price forecast at $20.00.

The Wall Street analyst predicted that Bio Path Holdings's share price could reach $20.00 by Jul 8, 2025. The average Bio Path Holdings stock price prediction forecasts a potential upside of 2,250.18% from the current BPTH share price of $0.85.

What is BPTH's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: BPTH) Bio Path Holdings's current Earnings Per Share (EPS) is -$16.67. On average, analysts forecast that BPTH's EPS will be -$6.20 for 2024, with the lowest EPS forecast at -$6.20, and the highest EPS forecast at -$6.20. On average, analysts forecast that BPTH's EPS will be -$4.04 for 2025, with the lowest EPS forecast at -$4.04, and the highest EPS forecast at -$4.04. In 2026, BPTH's EPS is forecast to hit -$3.91 (min: -$3.91, max: -$3.91).

What is BPTH's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BPTH) forecast ROE is -747.27%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.